As of October 23, 2026, a change in major shareholders was confirmed. Silchester International Investors LLP has become a new major shareholder with a holding ratio of 10.27%. The number of voting rights remained from 33,050,300 shares to 33,050,300 shares, and the post-change voting rights ratio is 10.27%. No specific future outlook was disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4536","jir_company_name":"Santen Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/4536-20261027-01.pdf","jir_short_summary":"As of October 23, 2026, a change in major shareholders was confirmed. Silchester International Investors LLP has become a new major shareholder with a holding ratio of 10.27%. The number of voting rights remained from 33,050,300 shares to 33,050,300 shares, and the post-change voting rights ratio is 10.27%. No specific future outlook was disclosed.","jir_summary":"### Overview\nA change in major shareholders was confirmed as of October 23, 2026. Silchester International Investors LLP has strengthened its position as a major shareholder, holding 330,503 shares and representing 10.27% of the total shareholders' voting rights. The change is based on a large-shareholding report submitted on October 26, 2026, and the before-and-after figures were published based on filings submitted to the Financial Services Agency.\n\n### Impact and Outlook\nWhile this shareholder change indicates a sizable shift in the market's major shareholder composition, no direct impact on Santen's business plans or shareholder return policy is described. Continued monitoring is required for future movements in shareholder composition and potential effects on capital policy.","jir_financial_highlights":"Percentage of total shareholders' voting rights: 10.27% (Before change 9.72% \u2192 After change 10.27%)\nNumber of voting rights (number of shares held): 315,605 shares \u2192 330,503 shares (+14,898 shares)","jir_category":"","jir_hashtags":"#SantenShareholderChange","jir_key_figures":"Major shareholder voting rights ratio: 10.27%\nNumber of voting rights after change: 330,503 shares\nPost-change percentage of total shareholders' voting rights: 10.27%","jir_meta_title":"Santen Pharmaceutical Co., Ltd. - Notice of Change in Major Shareholders | October 2026","jir_meta_description":"Notice regarding a change in major shareholders of Santen Pharmaceutical Co., Ltd. Silchester International Investors LLP has become a new major shareholder, with a post-change voting rights ratio of 10.27%. Future impact is unknown.","jir_og_title":"Notice of Change in Major Shareholders of Santen Pharmaceutical Co., Ltd. | October 2026","jir_og_description":"Announcement of a major shareholder change involving Silchester International Investors LLP. The post-change voting rights ratio is 10.27%; the future impact is currently unknown.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7842,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-134480","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n